PAREXEL International (PRXL) Forms Company Dedicated to China-Specific Approvals
9/30/2013 1:17:28 PM
by Richard Daverman, PhD
September 30, 2013 -- Parexel, the US clinical-stage CRO, has formed Ding Hui China Trials Solution, a Beijing company that is dedicated entirely to conducting trials that will gain product approvals in China. The rest of Parexel’s China offices participate in global clinical trials as well as China-specific tests. More details....
Stock Symbol: (NSDQ: PRXL)
Help employers find you! Check out all the jobs and post your resume.
comments powered by